Cliantha Research Full Service CRO Research delivered with Integrity

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Read More

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "#Immunogenicity and approach to correlate immunological adverse events in case of #Biosimilars" at National Conference on #Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Research https://t.co/fVS8Q6qCnQ

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "#Immunogenicity and approach to correlate immunological adverse events in case of #Biosimilars" at National Conference on #Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Research https://t.co/fVS8Q6qCnQ

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "#Immunogenicity and approach to correlate immunological adverse events in case of #Biosimilars" at National Conference on #Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Research https://t.co/fVS8Q6qCnQ

Read More

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Mr. Nilesh Patel, from large molecule lab, presented a poster titled "Immunogenicity and approach to correlate immunological adverse events in case of Biosimilars" at National Conference on Pharmacovigilance, Ayush Suraksha on 9th – 10th November’19 at Jamnagar. #Pharma #Research #ClinicalTrials #GlobalCRO #ClinicalResearch

Read More

Shaifali Gupta (M.D.), Director - Large Molecule & Clinical Lab services will conduct a session on "#Biomarker Bioanalysis - Case Studies" at APA India 2018 on 26th February 2018. Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. #ClianthaResearch is recognized among the “#Top 5 #CROs for the conduct of #Biosimilar Clinical Trials Globally" by Global Data Report, April 2017.

Shaifali Gupta (M.D.), Director - Large Molecule & Clinical Lab services will conduct a session on "#Biomarker Bioanalysis - Case Studies" at APA India 2018 on 26th February 2018. Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. #ClianthaResearch is recognized among the “#Top 5 #CROs for the conduct of #Biosimilar Clinical Trials Globally" by Global Data Report, April 2017.

Shaifali Gupta (M.D.), Director - Large Molecule & Clinical Lab services will conduct a session on "#Biomarker Bioanalysis - Case Studies" at APA India 2018 on 26th February 2018. Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. #ClianthaResearch is recognized among the “#Top 5 #CROs for the conduct of #Biosimilar Clinical Trials Globally" by Global Data Report, April 2017.

Read More

Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. Cliantha Research is recognized among the “Top 5 CROs for the conduct of Biosimilar Clinical Trials Globally" by Global Data Report, April 2017. Dr. Chirag Shah, Director - Late Phase Trials will speak on "Regulatory considerations in Clinical Study Design of Biosimilars" at 12th Biosimilars Congregation 2018 in London, UK, on 27th & 28th February 2018. If you wish to set up a meeting with Dr. Chirag Shah, during the event contact us at cshah@cliantha.in.

Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. Cliantha Research is recognized among the “Top 5 CROs for the conduct of Biosimilar Clinical Trials Globally" by Global Data Report, April 2017. Dr. Chirag Shah, Director - Late Phase Trials will speak on "Regulatory considerations in Clinical Study Design of Biosimilars" at 12th Biosimilars Congregation 2018 in London, UK, on 27th & 28th February 2018. If you wish to set up a meeting with Dr. Chirag Shah, during the event contact us at cshah@cliantha.in.

Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. Cliantha Research is recognized among the “Top 5 CROs for the conduct of Biosimilar Clinical Trials Globally" by Global Data Report, April 2017. Dr. Chirag Shah, Director - Late Phase Trials will speak on "Regulatory considerations in Clinical Study Design of Biosimilars" at 12th Biosimilars Congregation 2018 in London, UK, on 27th & 28th February 2018. If you wish to set up a meeting with Dr. Chirag Shah, during the event contact us at cshah@cliantha.in.

Read More